Novobiocin inhibits initiation of RNA polymerase II-directed transcription of the mouse metallothionein-I gene independent of its effect on DNA topoisomerase II

Nucleic Acids Res. 1987 Oct 26;15(20):8547-60. doi: 10.1093/nar/15.20.8547.

Abstract

The requirement for ATP hydrolysis in the initiation of RNA polymerase II (Pol II)-directed transcription and the relationship between ATP and novobiocin action led us to investigate whether novobiocin could inhibit transcription of the mouse metallothionein-I (MT-I) gene. Novobiocin inhibited the MT-I gene transcription in a fractionated rat hepatoma nuclear extract in a dose-dependent manner by direct interaction with a nuclear factor(s). This interaction prevented formation of stable preinitiation complexes but did not affect elongation of MT-I mRNA. Preincubation of the nuclear extract with ATP prevented the action of novobiocin on MT-I gene transcription. Although novobiocin is known to inhibit DNA topoisomerase II, VM-26, a specific inhibitor of this enzyme had no effect on the transcription. These results indicate that novobiocin blocks the Pol II-directed transcription by inhibiting formation of preinitiation complexes at an ATP-dependent step.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Nucleus / enzymology
  • DNA Restriction Enzymes
  • DNA Topoisomerases, Type II / metabolism*
  • Genes / drug effects*
  • Liver Neoplasms, Experimental / enzymology
  • Metallothionein / genetics*
  • Mice
  • Novobiocin / pharmacology*
  • RNA Polymerase II / antagonists & inhibitors*
  • Transcription, Genetic / drug effects*

Substances

  • Novobiocin
  • Metallothionein
  • RNA Polymerase II
  • DNA Restriction Enzymes
  • DNA Topoisomerases, Type II